vialroom

#semaglutide 2026-04-02

Thursday65 messages12 participantstimes are UTC
Highlights from this day
  • a1c_lag — does moving my dose day by two days matter with a seven day half life 16:03
  • electrolyte_eli — quick one brand vs compounded, is there a difference people can actually feel 16:51
  • two_lifts_a_week — vial units and pen clicks are different systems, mixing the two is how people end up wrong 19:08
  • electrolyte_eli — i dont think the plateau is a dose problem most of the time, but i cant prove that 20:01
A1

does moving my dose day by two days matter with a seven day half life

🧊1📈15🎉12
A1

my PeptideMeter report on the MKM vial came back 99.4 against a certificate saying 98.6

i held at 7.5 for 5 months and it was the best decision i made

*Janoshik not the other one

how long did the first 40kg take for people at the low doses
i held at 12 for 8 months and it was the best decision i made

is the plateau at 7 weeks normal or am i doing something wrong

LM

dose day is sunday for me only because thats when i remember, not because sunday matters

my plateau was the scale stopping while appetite stayed suppressed, which is a different problem

HL

i was wrong about the ceiling for a year, i thought 3 existed. it doesnt for the weight indication

janoshik-b-0114.pdf
2 pages · 371 KB · not retained in the public archive
HL

compounded and brand felt the same to me at 1.7, which is one person and nothing more

[edited]

thats STEP 1

FA

my dose day drifted from friday to sunday, does that reset anything

what did SELECT actually measure, i see it quoted for everything

EE

quick one brand vs compounded, is there a difference people can actually feel

📈6🙏10🎉1

moving my dose day by a day or two never did anything noticeable for me

is 2.4 the top or do people go past it

Cited study
Effects of Semaglutide on Chronic Kidney Disease in Type 2 Diabetes (FLOW)
New England Journal of Medicine · 2024
Renal outcomes. The one that changed a lot of nephrologists’ minds.
EE

if youre comparing brand to compounded, dose accuracy in the vial is the variable, not the molecule

five week steps worked better for me than four, purely on how the second week felt

NE

went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down
the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing

EM

SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

EM

ok so back after 5 months off, do i restart at 0.25 or somewhere higher
i dont think the plateau is a dose problem most of the time, but i cant prove that

anyone gone from 12 straight to 0.5 or is that too big a jump

Cited study
Effect of Semaglutide Coadministered with Intensive Behavioural Therapy (STEP 3)
JAMA · 2021
Semaglutide plus intensive behavioural therapy and a low-calorie diet run-in.
HL

is the plateau usually appetite coming back or just the scale stopping

my 40 vial in 2.5ml gives 5mg/ml so 2.5 lands on 10 units, thats why i picked that volume

did anyone hold at 2 longer than four weeks before going up

wk 1-4    0.25mg
wk 5-10   0.50mg   (held 2 extra weeks)
wk 11-14  1.00mg
wk 15-26  1.70mg   (held, long)
wk 27+    2.40mg
EM

does the licensed ceiling for weight differ from the diabetes one

EM

the long half life flattens the trough more than people expect, i never felt a day seven dip

did anybody find a difference between Homopeptide and pharmacy at the same 15

EM

does the seven day half life mean the last two days are weaker

seven days ish

STEP is several trials, so saying STEP said x is usually wrong without a number after it

mine faded too

same dose day

[edited]

whats the actual licensed ceiling, i keep seeing different numbers

II

STEP 4 had the withdrawal arm, thats the one people quote when they talk about stopping
changed my mind on the four week rule, i think it depends entirely on how the current dose feels

TL

half life is about a week so youre roughly four to five weeks to steady state on any new dose

vial units and pen clicks are different systems, mixing the two is how people end up wrong

Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance
🧪1

FLOW was the kidney outcomes trial and it gets quoted in here for things it didnt measure

HI

the appetite effect faded for me around 25 months and going up fixed it for a while, happy to be corrected

lost about 28kg on the low doses before i even got to 1, which surprised me

steady state is the bit people skip, judging a new dose after eight days tells you almost nothing

i stayed on 1.7 for 10 months and never went to 2.4, appetite was already where i needed it

wk 1-4    0.25mg
wk 5-10   0.50mg   (held 2 extra weeks)
wk 11-14  1.00mg
wk 15-26  1.70mg   (held, long)
wk 27+    2.40mg
EE

went 1 to 1.7 too fast and spent two weeks regretting it, dropped back and repeated the step, thats one data point

RT

the plateau hit me at 10 weeks and moved again about a month later without a dose change

EE

i dont think the plateau is a dose problem most of the time, but i cant prove that

wk 1-4    0.25mg
wk 5-10   0.50mg   (held 2 extra weeks)
wk 11-14  1.00mg
wk 15-26  1.70mg   (held, long)
wk 27+    2.40mg
👍14
RT

licensed ceiling for weight is 2.4 weekly, anything above that is not a licensed dose